Jupiter Life Line (JLHL) | Financial Analysis & Statements
Jupiter Life Line Hospitals Limited Mid-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
3.5B
Gross Profit
2.8B
80.33%
Operating Income
569.2M
16.37%
Net Income
438.8M
12.62%
EPS (Diluted)
₹6.69
Balance Sheet Metrics
Total Assets
19.0B
Total Liabilities
5.5B
Shareholders Equity
13.6B
Debt to Equity
0.40
Cash Flow Metrics
Revenue & Profitability Trend
Quarter Income Flow
Jun 30, 2025
Annual Income Flow
2025
Jupiter Life Line Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 12.6B | 10.7B | 8.9B | 7.3B | 4.9B |
| Cost of Goods Sold | 2.6B | 2.1B | 1.8B | 1.6B | 1.1B |
| Gross Profit | 10.0B | 8.6B | 7.1B | 5.7B | 3.7B |
| Gross Margin % | 79.3% | 80.0% | 79.7% | 78.2% | 76.9% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 3.1B | 2.7B | 2.2B | 1.8B | 1.2B |
| Other Operating Expenses | 1.6B | 1.4B | 1.2B | 949.8M | 720.3M |
| Total Operating Expenses | 4.7B | 4.1B | 3.4B | 2.7B | 1.9B |
| Operating Income | 2.4B | 2.0B | 1.6B | 1.2B | 390.7M |
| Operating Margin % | 19.3% | 18.5% | 18.4% | 16.1% | 8.0% |
| Non-Operating Items | |||||
| Interest Income | 199.6M | 193.9M | 68.0M | 17.0M | 29.6M |
| Interest Expense | 34.2M | 226.6M | 387.4M | 366.5M | 314.6M |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | 2.6B | 2.0B | 1.3B | 771.2M | 15.6M |
| Income Tax | 642.0M | 188.0M | 558.0M | 259.9M | 38.5M |
| Effective Tax Rate % | 24.9% | 9.6% | 43.4% | 33.7% | 247.7% |
| Net Income | 1.9B | 1.8B | 729.0M | 511.3M | -23.0M |
| Net Margin % | 15.4% | 16.5% | 8.2% | 7.0% | -0.5% |
| Key Metrics | |||||
| EBITDA | 3.1B | 2.6B | 2.1B | 1.5B | 664.0M |
| EPS (Basic) | ₹29.47 | ₹28.65 | ₹11.12 | ₹7.80 | ₹-0.35 |
| EPS (Diluted) | ₹29.47 | ₹28.65 | ₹11.12 | ₹7.80 | ₹-0.35 |
| Basic Shares Outstanding | 65566022 | 61570328 | 65566022 | 65566022 | 65566022 |
| Diluted Shares Outstanding | 65566022 | 61570328 | 65566022 | 65566022 | 65566022 |
Income Statement Trend
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Jupiter Life Line Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 3.7B | 3.0B | 1.3B | 1.0B | 194.4M |
| Short-term Investments | 2.3B | 168.7M | 14.0M | 27.3M | 72.1M |
| Accounts Receivable | 418.9M | 572.1M | 456.9M | 278.7M | 218.4M |
| Inventory | 241.0M | 213.4M | 190.0M | 153.6M | 130.5M |
| Other Current Assets | 9.1M | 190.0K | 130.0K | 1.8M | 750.0K |
| Total Current Assets | 6.9B | 4.1B | 2.1B | 1.8B | 1.1B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 3.6B | 3.4B | 3.1B | 2.7B | 879.3M |
| Goodwill | 45.5M | 21.3M | 7.5M | 8.3M | 5.5M |
| Intangible Assets | 45.5M | 21.3M | 7.5M | 8.3M | 5.5M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | -50.0K | -10.0K | - | - | - |
| Total Non-Current Assets | 12.2B | 8.7B | 7.8B | 7.3B | 6.8B |
| Total Assets | 19.0B | 12.8B | 9.9B | 9.1B | 7.9B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 1.0B | 622.4M | 707.3M | 611.1M | 585.7M |
| Short-term Debt | 90.6M | 0 | 161.2M | 307.3M | 43.7M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 91.1M | 54.5M | 64.1M | 42.9M | 36.3M |
| Total Current Liabilities | 1.5B | 1.1B | 1.3B | 1.2B | 958.5M |
| Non-Current Liabilities | |||||
| Long-term Debt | 3.8B | 0 | 4.5B | 4.6B | 4.2B |
| Deferred Tax Liabilities | 71.2M | 37.4M | 369.8M | 325.4M | 254.6M |
| Other Non-Current Liabilities | 400.0K | 31.0M | - | - | - |
| Total Non-Current Liabilities | 4.0B | 68.4M | 4.9B | 5.0B | 4.5B |
| Total Liabilities | 5.5B | 1.1B | 6.2B | 6.2B | 5.4B |
| Equity | |||||
| Common Stock | 655.7M | 655.7M | 565.2M | 508.7M | 508.7M |
| Retained Earnings | 5.5B | 3.8B | 2.3B | 2.0B | 1.6B |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 13.6B | 11.7B | 3.6B | 2.9B | 2.5B |
| Key Metrics | |||||
| Total Debt | 3.9B | 0 | 4.7B | 5.0B | 4.3B |
| Working Capital | 5.3B | 3.0B | 771.2M | 572.4M | 169.1M |
Balance Sheet Composition
Jupiter Life Line Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 2.6B | 2.0B | 1.3B | 771.2M | 15.6M |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | - | - | - | - | - |
| Working Capital Changes | 126.9M | -724.2M | -638.6M | -86.0M | 631.5M |
| Operating Cash Flow | 2.6B | 1.3B | 1.0B | 1.1B | 1.0B |
| Investing Activities | |||||
| Capital Expenditures | -3.2B | -851.7M | -767.1M | -910.7M | -2.4B |
| Acquisitions | 31.2M | 13.0M | -211.9M | -46.0M | -569.5M |
| Investment Purchases | -3.4B | -254.9M | -119.5M | - | - |
| Investment Sales | 4.3B | 99.1M | 0 | - | - |
| Investing Cash Flow | -2.3B | -994.5M | -1.1B | -950.0M | -3.0B |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | -65.6M | -56.5M | -50.9M | - | - |
| Debt Issuance | - | 1.0B | 486.8M | 643.7M | 1.7B |
| Debt Repayment | - | -5.7B | -178.0M | -120.6M | -267.4M |
| Financing Cash Flow | -25.9M | 1.4B | -234.0M | 761.4M | 2.1B |
| Free Cash Flow | -674.2M | 292.3M | 399.2M | 452.4M | -1.2B |
| Net Change in Cash | 302.2M | 1.7B | -288.0M | 916.2M | 99.6M |
Cash Flow Trend
Jupiter Life Line Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
43.84
Forward P/E
38.52
Price to Book
5.71
Price to Sales
5.88
PEG Ratio
-1.39
Profitability Ratios
Profit Margin
13.45%
Operating Margin
16.89%
Return on Equity
14.27%
Return on Assets
10.16%
Financial Health
Current Ratio
3.97
Debt to Equity
27.81
Beta
0.32
Per Share Data
EPS (TTM)
₹28.82
Book Value per Share
₹221.36
Revenue per Share
₹214.67
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| JLHL | 82.8B | 43.84 | 5.71 | 14.27% | 13.45% | 27.81 |
| Apollo Hospitals | 1.1T | 61.08 | 12.11 | 16.71% | 7.44% | 83.61 |
| Max Healthcare | 979.8B | 68.81 | 9.77 | 11.47% | 17.43% | 32.58 |
| Rainbow Children's | 128.6B | 50.33 | 8.50 | 16.50% | 15.97% | 53.24 |
| Healthcare Global | 85.1B | 438.11 | 8.81 | 4.49% | 0.77% | 177.91 |
| Yatharth Hospital | 69.2B | 43.38 | 4.31 | 7.97% | 15.29% | 1.53 |
Financial data is updated regularly. All figures are in the company's reporting currency.





